Home / Companies / Editas Medicine, Inc. / 17 Jun 2026
Editas Medicine, Inc.: meeting of 17 Jun 2026
Votes reported on Form N-PX, item by item
301 Form N-PX filers reported votes at the Editas Medicine, Inc. meeting of 17 Jun 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 69.1% of reported votes for; 44 filers withheld from or voted against at least one nominee.
282 vote records from 76 filers. 4 of the 76 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
398 vote records from 300 filers. 115 of the 283 filers that marked the item either way voted against management. 17 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
141 vote records from 76 filers. 1 of the 76 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| Dimensional | No report | Against * | No report |
| State Street and SPDR | For | For | For |
| Invesco | For | Against * | For |
| Equitable | Abstain or withhold * | For | For |
| Charles Schwab | For | For | For |
| Nuveen and TIAA | For | For | For |
| ProShares and ProFunds | Split or no vote | Against * | For |
| John Hancock and Manulife | Split or no vote | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | Split or no vote | Against * | For |
| J.P. Morgan | For | For | For |
| Goldman Sachs | Split or no vote | For | For |
| WisdomTree | Split or no vote | For | For |
| PGIM and Prudential | No report | Against * | No report |
| Northern Trust and FlexShares | Abstain or withhold * | Against * | For |
| SEI | For | For | For |
| T. Rowe Price | Split or no vote | Against * | For |
| Lincoln Financial | For | For | For |
| Voya | Split or no vote | For | For |
| First Trust | No report | Against * | No report |
| Russell Investments | For | For | For |
| Nationwide | For | Against * | For |
| Victory Capital | Split or no vote | Against * | For |
| Brighthouse Funds | For | For | For |
| Guggenheim and Rydex | Split or no vote | Against * | For |
| Columbia Threadneedle | Split or no vote | Against * | For |
| BNY Mellon | No report | For | No report |
| Principal | Split or no vote | Against * | For |
| Pacific Life funds | Split or no vote | For | For |
| Global X | For | For | For |
| Federated Hermes | No report | For | No report |
| AllianceBernstein | No report | Against * | No report |
| DWS | Split or no vote | Against * | For |
| Allspring | No report | Split or no vote | No report |
| MassMutual | No report | For | No report |
| Neuberger Berman | No report | For | No report |
| Harris Associates and Oakmark | No report | Against * | No report |
| Baird | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Editas Medicine, Inc. meeting?
301 Form N-PX filers reported votes at the meeting of 17 Jun 2026. On say-on-pay, 115 of 283 voted against management (40.6%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Editas Medicine, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Editas Medicine, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Editas Medicine, Inc. with a meeting date within three days of 17 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.